Fatemeh Akhlaghi

Fatemeh Akhlaghi is a seasoned expert in clinical pharmacology with a robust academic and industry background. Currently serving as Senior Director and Head of Clinical Pharmacology at Ventyx Biosciences, Fatemeh leads the strategy and execution of clinical pharmacology and Modeling & Simulation efforts for multiple clinical assets. Previous roles include Director of Clinical Pharmacology at Pfizer and Global Blood Therapeutics, as well as establishing a renowned clinical pharmacology group at the University of Rhode Island, where Fatemeh held the Ernest Mario Distinguished Chair and advanced through academic ranks to full professor. In addition to consulting for biotech companies and law firms as a clinical pharmacology expert witness, Fatemeh has contributed to various academic institutions, including as an adjunct professor at Brown University and a consultant for Takeda Oncology. Fatemeh holds a PhD in Pharmaceutical Sciences from the University of Sydney and a PharmD from Ferdowsi University of Mashhad.